Relationship between the clinical response to adalimumab treatment and serum levels of adalimumab and anti-adalimumab antibodies in patients with psoriatic arthritis

被引：75
|
作者：
van Kuijk, A. W. R. [1 ,2 ]
de Groot, M. [3 ]
Stapel, S. O. [4 ]
Dijkmans, B. A. C. [2 ,5 ]
Wolbink, G. J. [2 ,4 ]
Tak, P. P. [1 ]
机构：
[1] Univ Amsterdam, Div Clin Immunol & Rheumatol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[2] Jan van Breemen Inst, Amsterdam, Netherlands
[3] Univ Amsterdam, Dept Dermatol, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands
[4] Sanquin Res, Amsterdam, Netherlands
[5] Vrije Univ Amsterdam, Dept Rheumatol, Med Ctr, Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2010年 / 69卷 / 03期
关键词：
RHEUMATOID-ARTHRITIS; CRITERIA; VALIDATION;
D O I：
10.1136/ard.2009.108787
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：624 / U187
页数：2
相关论文
共 50 条
  • [31] Anti-adalimumab antibodies in juvenile idiopathic arthritis: frequent association with loss of response
    Skrabl-Baumgartner, A.
    Erwa, W.
    Muntean, W.
    Jahnel, J.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2015, 44 (05) : 359 - 362
  • [32] Adalimumab for the treatment of psoriatic arthritis
    Poddubnyy, Denis A.
    Rudwaleit, Martin
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2009, 5 (06) : 671 - 681
  • [33] THE ASSOCIATION BETWEEN 6-THIOGUANINE NUCLEOTIDE LEVELS, ADALIMUMAB DRUG CONCENTRATIONS, ANTI-ADALIMUMAB ANTIBODIES AND DRUG CLEARANCE
    Yarur, Andres
    Abraham, Bincy P.
    Conklin, John
    Everts-van der Wind, Annelie
    Hanauer, Stephen B.
    Dervieux, Thierry
    GASTROENTEROLOGY, 2024, 166 (05) : S829 - S829
  • [34] Characteristics of Patients with Adalimumab therapy that were Anti-adalimumab Antibodies Positive but Later turned Negative
    Or, Chris
    Hung, Jia-Horung
    Khatri, Anadi
    Bazojoo, Vahid
    Akhavanrezayat, Amir
    Nguyen, Quan Dong
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2024, 65 (07)
  • [35] Adalimumab serum levels and anti -drug antibodies: association to treatment response and drug survival in inflammatory arthritis patients
    Jyssum, I.
    Gehin, J.
    Sexton, J.
    Kristianslund, E.
    Hu, Y.
    Warren, D.
    Kvien, T.
    Haavardsholm, E.
    Syversen, S.
    Bolstad, N.
    Goll, G.
    SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2023, 52 : 34 - 36
  • [36] Early Adalimumab and Anti-Adalimumab Antibody Levels for Prediction of Primary Nonresponse in Ankylosing Spondylitis Patients
    Ding, Xiaoliang
    Zhu, Ruifang
    Wu, Jian
    Xue, Ling
    Gu, Meihua
    Miao, Liyan
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2020, 13 (03): : 547 - 554
  • [37] AdalimumabDevelopment of anti-adalimumab antibodies: case report
    Reactions Weekly, 2018, 1732 (1) : 22 - 22
  • [38] Anti-adalimumab antibodies in juvenile idiopathic arthritis-related uveitis
    Leinonen, S. T.
    Aalto, K.
    Kotaniemi, K. M.
    Kivela, T. T.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : 1043 - 1046
  • [39] ANTI-ADALIMUMAB ANTIBODIES IN JUVENIL IDIOPATHIC ARTHRITIS AND LOSS OF RESPONSE. PRELIMINARY STUDY
    Masegosa, S.
    Copete, S.
    Jimenez, R.
    Collantes, E.
    Roldan, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1203 - 1204
  • [40] Anti-Adalimumab Antibodies in Patients with Noninfectious Uveitis Who Use Adalimumab Weekly or Every Other Week
    Ismayilova, Leman
    Eser-Ozturk, Hilal
    Birinci, Asuman
    Sullu, Yuksel
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2025,
12345